These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 32776356)

  • 1. Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record.
    Tillman EM; Suppes SL; Feldman K; Goldman JL
    J Clin Pharmacol; 2021 Feb; 61(2):181-186. PubMed ID: 32776356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for Detecting Pediatric Adverse Drug Reactions From the Electronic Medical Record.
    Joyner LM; Alicea LA; Goldman JL; Suppes SL; Tillman EM
    J Clin Pharmacol; 2021 Nov; 61(11):1479-1484. PubMed ID: 34031886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Severe Adverse Drug Reactions at a Free-Standing Children's Hospital.
    Yu D; Sheets J; Suppes S; Goldman J
    J Clin Pharmacol; 2019 Dec; 59(12):1569-1572. PubMed ID: 31309572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completeness and accuracy of adverse drug reaction documentation in electronic medical records at a tertiary care hospital in Australia.
    McLachlan G; Broomfield A; Elliott R
    Health Inf Manag; 2023 May; 52(2):108-111. PubMed ID: 34930047
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
    Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
    Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarification of adverse drug reactions by a pharmacovigilance team results in increased antibiotic re-prescribing at a freestanding United States children's hospital.
    Feldman K; Suppes SL; Goldman JL
    PLoS One; 2024; 19(1):e0295410. PubMed ID: 38215178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.
    Fossouo Tagne J; Yakob RA; Dang TH; Mcdonald R; Wickramasinghe N
    JMIR Public Health Surveill; 2023 Jan; 9():e40080. PubMed ID: 36645706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
    Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A
    J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of documentation of patient reported adverse drug reactions on both paper-based medication charts and electronic medication charts at a New Zealand hospital.
    Shen W; Wong B; Chin JY; Lee M; Coulter C; Braund R
    N Z Med J; 2016 Oct; 129(1444):90-96. PubMed ID: 27806032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor reporting and documentation in drug-associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis - Lessons for medication safety.
    Goldblatt C; Khumra S; Booth J; Urbancic K; Grayson ML; Trubiano JA
    Br J Clin Pharmacol; 2017 Feb; 83(2):224-226. PubMed ID: 27558920
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports.
    Leitzen S; Dubrall D; Toni I; Stingl J; Christ P; Köberle U; Schmid M; Neubert A; Sachs B
    Paediatr Drugs; 2023 Mar; 25(2):203-215. PubMed ID: 36369590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
    Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
    Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
    Krishnappa L; Gadicherla S; Chidambaram P; Anuradha HV; Somanna SN; Naik PR; Das A; Narasimhaiah S; Nagaraja SB
    Indian J Tuberc; 2020 Jan; 67(1):20-28. PubMed ID: 32192612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication Allergy and Adverse Drug Reaction Documentation Discrepancies in an Urban, Academic Emergency Department.
    Kiechle ES; McKenna CM; Carter H; Zeymo A; Gelfand BW; DeGeorge LM; Sauter DA; Mazer-Amirshahi M
    J Med Toxicol; 2018 Dec; 14(4):272-277. PubMed ID: 29968185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal.
    Ribeiro-Vaz I; Santos C; da Costa-Pereira A; Cruz-Correia R
    Drug Saf; 2012 May; 35(5):387-94. PubMed ID: 22468615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital registration of adverse drug reactions in electronic health records: importance and contribution to pharmacovigilance.
    Alloush R; van Lint J; van Marum RJ; Hermens WWAJJ; Jessurun NT
    Expert Opin Drug Saf; 2024 Jul; 23(7):925-935. PubMed ID: 37961907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009.
    Aldea A; García Sánchez-Colomer M; Fernández Quintana E; García Sáiz M
    Eur J Clin Pharmacol; 2012 Sep; 68(9):1329-38. PubMed ID: 22415248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.